Multimodal retinal imaging provides "insight" into cerebrovascular ageing. Multimodal retinal imaging provides "insight" into cerebrovascular ageing. This project aims to develop a multi-modal imaging technology platform to simultaneously measure amyloid beta and its neurovascular sequelae to identify novel early biomarkers of ageing in the eye and brain. The growing ageing population is an increasing socioeconomic burden. The central nervous system is particularly susceptible to ageing, which i ....Multimodal retinal imaging provides "insight" into cerebrovascular ageing. Multimodal retinal imaging provides "insight" into cerebrovascular ageing. This project aims to develop a multi-modal imaging technology platform to simultaneously measure amyloid beta and its neurovascular sequelae to identify novel early biomarkers of ageing in the eye and brain. The growing ageing population is an increasing socioeconomic burden. The central nervous system is particularly susceptible to ageing, which is difficult to measure at its onset. Critically, as the eye is an easily accessible extension of the cortex, retinal imaging may be a non-invasive surrogate to assess ageing changes in the brain. Anticipated outcomes are a sensitive detector of neural ageing, improved preventative measures, reducing the socioeconomic burden of ageing, and improved quality of life.Read moreRead less
Developing tests for the early detection of eye disease. Australians have a tradition of innovative design in perimetry. A good example being the Frequency Doubling Technology produced from work performed at the Australian National University. This technology, however, is manufactured by an overseas company (Welch Allyn, NY, USA). The Medmont company is a local perimeter manufacturer and we hope to improve their product with innovative design to yield a distinct marketing advantage. We will cons ....Developing tests for the early detection of eye disease. Australians have a tradition of innovative design in perimetry. A good example being the Frequency Doubling Technology produced from work performed at the Australian National University. This technology, however, is manufactured by an overseas company (Welch Allyn, NY, USA). The Medmont company is a local perimeter manufacturer and we hope to improve their product with innovative design to yield a distinct marketing advantage. We will consider the fundamental issues underlying cone-interactions and methods that stress retinal function. We believe that this approach will have advantages over conventional techniques and prove more sensitive for the early detection of eye disease. However, this is a high risk venture requiring substantial developmental cost and technical commitment by the company. Successful innovation will enhance the company's international penetration, continue the trend for Australians to be seen as leaders in this field and have impact on eye care.Read moreRead less